Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × Exercise × Clear all

Phase

Status

Active not recruiting 3 Unknown 1 Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Motor Activity 98 Breast Neoplasms 59 Neoplasms 41 Prostatic Neoplasms 17 Obesity 13 Fatigue 12 Colorectal Neoplasms 10 Lung Neoplasms 9 Polycystic Ovary Syndrome 8 Colonic Neoplasms 8 Head and Neck Neoplasms 7 Ovarian Neoplasms 6 Weight Loss 5 Rectal Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Multiple Myeloma 4 Cognitive Dysfunction 4 Brain Neoplasms 4 Overweight 3 Lymphoma, Follicular 3 Lymphedema 3 Leukemia, Myeloid, Acute 3 Insulin Resistance 3 Inflammation 3 Carcinoma, Non-Small-Cell Lung 3 Breast Cancer Lymphedema 3 Breast Cancer Female 3 Urinary Bladder Neoplasms 2 Sleep Initiation and Maintenance Disorders 2 Sarcopenia 2

Interventions

Gemcitabine 311 Fluorouracil 78 Oxaliplatin 65 Capecitabine 61 Albumin-Bound Paclitaxel 58 130-nm albumin-bound paclitaxel 57 Radiotherapy 56 Leucovorin 45 Erlotinib Hydrochloride 43 Cisplatin 40 Irinotecan 39 Radiosurgery 29 Bevacizumab 27 Docetaxel 25 pembrolizumab 23 Taxes 22 Nivolumab 20 Cetuximab 19 Pancreaticoduodenectomy 16 Radiation 13 Drug Therapy 13 Cyclophosphamide 13 Endoscopic Ultrasound-Guided Fine Needle Aspiration 12 Neoadjuvant Therapy 11 irinotecan sucrosofate 10 folfirinox 10 Sorafenib 10 S 1 (combination) 10 Ipilimumab 10 Biopsy, Fine-Needle 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03187028 2021-11-18

PACE

University of Alabama at Birmingham

Phase NA Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡